References
- Aguirre K.M., Gibson G.W. Differing Requirement for Inducible Nitric Oxide Synthase Activity in Clearance of Primary and Secondary Cryptococcus Neoformans Infection. Med Mycol. 2000; 38: 343–353
- Connor T.J., Connelly D.B., Kelly J.P. Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) Suppresses Antigen Specific IgG2a and IFN γ Production. Immunology Letters 2001; 78: 67–73
- Connor T.J., Kelly J.P., Leonard B.E. An Assessment of the Acute Effects of the Serotonin Releasers Methylenedioxymethamphetamine, Methylenedioxy amphetamine and Fenfluramine on Immunity in Rats. Immunopharmacology 2000; 46: 223–235
- Connor T.J., Kelly J.P., McGee M., Leonard B.E. Methylenedioxymethamphetamine (MDMA; Ecstasy) Suppresses IL-1beta and Tnf-Alpha Secretion Following An In Vivo Lipopolysaccharide Challenge. Life Sciences 2000; 67: 1601–1612
- Friere-Garabal M., Balboa J.L., Nunez M.J., Castano M.T., Llovo J.B., Fernando Rial J.C., Belamonte A. Effects of amphatamine on T cell immune response in mice. Life Sciences 1991; 49: PL107–PL112
- Grob C.S., Poland R.E., Chang L., Ernst T. Psychobiologic Effects of 3,4-Methylenedioxymethamphetamine in Humans: Methodological Considerations and Preliminary Observations. Behav Brain Res. 1996; 73: 103–107
- House R.V., Thomas P.T., Bhargava H.N. Selective Modulation of Immune Function Resulting from In Vitro Exposure to Methylenedioxymethamphetamine (Ecstasy). Toxicology 1995; 96: 59–69
- Hultgren O.H., Stenson M., Tarkowski A. Role of IL-12 in Staphylococcus Aureus-Triggered Arthritis and Sepsis. Arthritis Res. 2001; 3: 41–47
- Jebbari H., Roberts C.W., Ferguson D.J., Bluethmann H., Alexander J. A Protective Role for IL-6 during Early Infection with Toxoplasma Gondii. Parasite Immunol. 1998; 20: 231–239
- King L.A. Drug Content of Powders and other Illicit Preparations in the UK. Forensic Science International 1997; 85: 135–147
- Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trincheiri G. Identification and Purification of Natural Killer Cell Stimulating Factor (NKSF) A Cytokine with Multiple Biologic Effects on Human Lymphocytes. J. Exp. Med. 1989; 70: 827–845
- Ladel C.H., Blum C., Dreher A., Reifenberg K., Kopf M., Kaufmann S.H. Lethal Tuberculosis in Interleukin-6-Deficient Mutant Mice. Infect Immun. 1997; 65: 4843–4849
- Lu H., Yang X., Takeda K., Zhang D., Fan Y., Luo M., Shen C., Wang S., Akira S., Brunham R.C. Chlamydia Trachomatis Mouse Pneumonitis Lung Infection in IL-18 and Il-12 Knockout Mice: Il-12 is Dominant over Il-18 for Protective Immunity. Mol Med. 2000; 6: 604–612
- MacLean A., Wei X.Q., Huang F.P., Al-Alem U.A., Chan W.L., Liew F.Y. Mice Lacking Inducible Nitric-Oxide Synthase are More Susceptible to Herpes Simplex Virus Infection Despite Enhanced Th1 Cell Responses. J. Gen. Virol. 1998; 79: 825–830
- Mattner F., Di Padova K., Alber G. Interleukin-12 is Indispensable for Protective Immunity Against Leishmania Major. Infect Immun. 1997; 65: 4378–4383
- Milroy C.M., Clark J.C., Forrest A.R. Pathology of Deaths Associated with “Ecstasy” and “Eve” Misuse. Clin Pathol. 1996; 49: 149–153
- Murray H.W., Nathan C.F. Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen Versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania Donovani. J. Exp. Med. 1999; 189: 741–746
- Nunez M.J., Fernandez Rial J.C., Couceiro J., Suarez J.A., Gomez-Fernando D.E., Rey-Mendez M., Friere-Garabal M. Effects of Amphetamine on Influeneza Infection in Mice. Life Sciences 1993; 53: L73–L78
- Park A.Y., Scott P. IL-12: Keeping Cell-Mediated Immunity Alive Scand J. Immunol. 2001; 53: 529–532
- Reiner S.L. Helper T Cell Differentiation, Inside and Out. Curr. Opin. Immunol. 2001; 13: 351–355
- Strestik B.D., Olbrich A.R., Hasenkrug K.J., Dittmer U. The Role of IL-5, IL-6 and IL-10 in Primary and Vaccine-primed Immune Responses to Infection with Friend Retrovirus (Murine Leukaemia Virus). J. Gen. Virol. 2001; 82: 1349–1354
- Thomassen M.J., Kavuru M.S. Human Alveolar Macrophages and Monocytes as a Source and Target for Nitric Oxide. Int. Immunopharmacol. 2001; 8: 1479–1490
- Tilg H., Dinarello C.A., Mier J.W. IL-6 and APPs: Anti-inflammatory and Immunosuppressive Mediators. Immunol Today 1997; 18: 428–432